Protein C levels as a prognostic indicator of outcome in sepsis and related diseases.
about
Human recombinant activated protein C for severe sepsisHuman recombinant protein C for severe sepsis and septic shock in adult and paediatric patientsHuman recombinant activated protein C for severe sepsisHuman recombinant activated protein C for severe sepsisDrotrecogin alfa (activated): the first FDA-approved treatment for severe sepsisBench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsisInflammation and haemostasisFoxA2 involvement in suppression of protein C, an outcome predictor in experimental sepsisAcute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency.New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective single-center observational study.Activated protein C action in inflammationSeveral Cytokines and Protein C Levels with the Apache II Scoring System for Evaluation of Patients with Sepsis.Recombinant human activated protein C, drotrecogin alfa (activated): a novel therapy for severe sepsis.Overexpression of activated protein C hampers bacterial dissemination during pneumococcal pneumonia.Effect of a multispecies probiotic on inflammatory markers in critically ill patients: A randomized, double-blind, placebo-controlled trial.Sepsis: a frequent, life-threatening syndrome.Protein C pathway in sepsis.Drotrecogin alfa (activated): a novel therapeutic strategy for severe sepsis.Inflammation and thrombosis.Sepsis and pathophysiology of anthrax in a nonhuman primate modelInteractions between coagulation and inflammation.New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated).Cellular mechanisms in sepsis.Effects of anticoagulant strategies on activation of inflammation and coagulation.Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.A comparative analysis of acute-phase proteins as inflammatory biomarkers in preclinical toxicology studies: implications for preclinical to clinical translation.Plasma protein C levels in immunocompromised septic patients are significantly lower than immunocompetent septic patients: a prospective cohort study.Protective mechanisms of activated protein C in severe inflammatory disorders.Sepsis biomarkers: a review.Inflammation and immunosuppression in severe acute pancreatitis.Ulinastatin - a newer potential therapeutic option for multiple organ dysfunction syndrome.Activated protein C ameliorates impaired renal microvascular oxygenation and sodium reabsorption in endotoxemic rats.The clinical course of acute pancreatitis and the inflammatory mediators that drive it.Protein C zymogen in severe sepsis: a double-blinded, placebo-controlled, randomized study.Intensive serial biomarker profiling for the prediction of neutropenic Fever in patients with hematologic malignancies undergoing chemotherapy: a pilot study.Successful treatment with Protein C of febrile neutropenia in pediatric patients during cancer therapy.Protein C and thrombomodulin in human acute lung injury.Antithrombin and heparin may limit the activation of Protein C.Alterations in the hemostatic profiles of dogs with naturally occurring septic peritonitis.Warfarin-induced skin necrosis associated with acquired protein C deficiency.
P2860
Q24201123-3A7CF514-3B95-444B-AD50-07BFC6B4BCE6Q24202128-B650F919-6DD8-4DFB-ADA7-B10CE8F7FA5BQ24235181-8FD83BFE-5641-40D3-9F13-84AF0A67032CQ24242859-C2E56E83-E1CD-4C95-9F88-6998B52DD1DEQ24536981-F271EB85-8964-4246-8975-A12831E0981DQ24794692-A76189CF-82F0-4793-9A1F-35922195510FQ26823258-B99A74AE-3B45-44B8-806F-7862D686A7B9Q28578891-04743841-B722-4D90-87C7-01B246FDE68BQ33373012-9EDD14E7-F694-4C0A-9B72-5EDA120BDBC0Q33754477-93A39329-BCB9-4415-A036-CB59C125B657Q33846825-9D301B41-9009-47C7-8933-9B8643DFFEE4Q33973581-D50B7B9F-7E2C-493B-811A-802B1AF97F80Q34443368-A567DC59-B75C-49DF-9C30-4E0463368C7CQ34491379-D8BC369F-F91D-42E7-92E9-D2121399670BQ34715954-E723990F-34D7-4155-922D-6A744F969CABQ35030565-E2958315-215B-4F96-B454-DB9E7D23036FQ35055016-F17D7915-CC9A-4D39-A078-AC2B308E8A12Q35059326-F787338E-F2D3-483D-B3AD-647578F62D89Q35181574-48B3A6CB-5465-4148-AF80-FAF4A6B3E4FFQ35221982-C0F36786-B285-411A-9095-010042C91AF4Q35585029-721A7108-2944-4B49-A5E9-77560B51EBA1Q36259602-480966DB-B977-40AD-AC0C-D164AA1B825BQ36800701-45E1FEB5-659C-4D80-9F64-C1C8BDC44613Q36842724-CE6C37E6-A8E2-47E9-AF75-61A266A38DB5Q37313286-F215D6D4-ACF0-4A7E-8DC8-6DE541AA015CQ37378327-951E78F5-6F05-4DD3-8559-AD022FA02FD4Q37409613-15862D58-A516-4C67-940F-19A3F259C49EQ37494702-38D1ADA0-CC08-4F94-BF3B-C3CF8460D840Q37689825-64081421-FF4A-4367-B9D8-0E99E4024473Q37765879-8849F0D4-4A48-44A4-8B4A-6FC2844F49CEQ38632598-4B7308BC-5CC4-4CED-93C0-6D1AF08D6562Q39110945-A866F83A-A9D1-4A77-854B-DD0D6C562B19Q39488367-14596A48-16B1-4A89-B569-18E43F4CDCADQ39654953-64B2CDC6-D846-4C1D-99AE-75B32ACA7E21Q40200631-63176E1B-7E04-478C-938C-ACF0ACF9F59BQ40396604-5C1BB068-C514-4EF0-97F1-92521A3B1BD8Q40646976-2EDF9100-21A8-4177-824F-1F36B72711EEQ43457307-94738E19-B34F-41F7-8A5A-D15C1FA7F8DAQ43764645-EDC1BEB8-A098-452F-97AD-FAEE816AC82FQ44311605-80D060D3-7AEA-4644-AADB-AD8576EEE898
P2860
Protein C levels as a prognostic indicator of outcome in sepsis and related diseases.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Protein C levels as a prognostic indicator of outcome in sepsis and related diseases.
@ast
Protein C levels as a prognostic indicator of outcome in sepsis and related diseases.
@en
Protein C levels as a prognostic indicator of outcome in sepsis and related diseases.
@nl
type
label
Protein C levels as a prognostic indicator of outcome in sepsis and related diseases.
@ast
Protein C levels as a prognostic indicator of outcome in sepsis and related diseases.
@en
Protein C levels as a prognostic indicator of outcome in sepsis and related diseases.
@nl
prefLabel
Protein C levels as a prognostic indicator of outcome in sepsis and related diseases.
@ast
Protein C levels as a prognostic indicator of outcome in sepsis and related diseases.
@en
Protein C levels as a prognostic indicator of outcome in sepsis and related diseases.
@nl
P1476
Protein C levels as a prognostic indicator of outcome in sepsis and related diseases.
@en
P2093
P304
P356
10.1097/00003246-200009001-00011
P407
P433
P577
2000-09-01T00:00:00Z